TATA Health (01255.HK) released its financial performance for the year 2024, with a net loss attributable to shareholders of 68.338 million Hong Kong dollars, a year-on-year increase of 111.6%.

Capital Communique APP news, TATA Health (01255.HK) released its annual performance for the year ending December 31, 2024, with a revenue of 124 million Hong Kong dollars, a year-on-year decrease of 40%; the company's attributable loss was 68.338 million Hong Kong dollars, a year-on-year increase of 111.6%; basic loss per share was 0.28 Hong Kong dollars.